Stock screener

LFCR

Conviction 26HealthcareScan · Mon, Aug 10, 2026
LFCR$4.67-6.79%
ResistanceSupportVol 14
63 bars
Vol MA14 156.91K
May 11May 28Jun 16Jul 6Jul 23Aug 10
LIFECORE BIOMEDICAL, INC. DEPHARMACEUTICAL PREPARATIONSwww.lifecore.com
Price4.67
Change-6.79%
Gap+0.10%
Rel volume1.70×
Avg volume151.5K
Avg $ vol695.04K
SMA 204.57
SMA 505.01
SMA 2006.18
Price vs 50-6.81%
Price vs 200-24.44%
MA stackbearish
50/200 cross
Supertrenddown · 5.07
RSI (14)50
MACD hist0.07
MACD crossbull · 3d
Stoch %K / %D58 / 80
ADX (14)17
+DI / −DI27 / 20
RSI divergence
MACD divergence
ATR %+5.97%
ADR %5.61%
52w high8.82
52w low3.66
From 52w high-47.05%
Above 52w low+27.60%
New 52w highNo
SqueezeOff
Bollinger width18.86%
%B0.62
Donchian pos43.89%
Donchian high5.29
Donchian low4.19
AVWAP (52w high)5.07
vs AVWAP high-7.84%
AVWAP (52w low)4.87
vs AVWAP low-4.18%
OBV trendFlat
Chaikin MF (20)-0.18
Today vs 20d1.70×
Avg vol (14d)156.91K
Avg vol (20d)151.5K
Avg $ vol (20d)695.04K
Market cap176.77M
RS 3m (vs SPY)-0.67%
RS 6m (vs SPY)-47.84%
RS line new highNo
Trend template0/8
Technical rank21.7
1 week+6.38%
1 month-1.68%
3 months-2.51%
6 months-38.31%
1 year-39.82%
YTD-39.66%
P/E-4.57
P/B-5.18
P/S0.32
P/FCF-12.98
EPS-1.27
Div yield
ROE113.56%
ROA-16.87%
Debt/Eq-3.27
Current3.87
EV/EBITDA-29.40
Gross margin7.23%
Net margin-6.94%
Rev growth6.36%
EPS growth-422.29%
Price target
Target upside
Analyst rating
Institutional
Ent. value271.03M
Revenue126.38M
Net income-6.16M
Gross profit12.07M
Free cash flow-13.62M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out37.51M
Employees382
ListedThu, Feb 15, 1996
Free float24.24M
Float %64.6%
Short interest2.48M
Days to cover14.7d
Short volume56.1%
Squeeze score67 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction26 / 100
Pattern quality
Tech rank21.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance5.73
Support4.21
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LFCR

All disclosures →
No recent disclosed trades by Congress in LFCR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LFCR · 4 buys

InsiderSideShares
Legion Partners Holdings, LLC
Director · Common Stock · 2026-06-04
Grant25.91K
Kiper Christopher S
Director · Common Stock · 2026-06-04
Grant25.91K
Legion Partners Asset Management, LLC
Director · Common Stock · 2026-06-04
Other
Legion Partners, L.P. II
Director · Common Stock · 2026-06-04
Grant25.91K
White Raymond T.
Director · Common Stock · 2026-06-04
Other
Kiper Christopher S
Director · Common Stock · 2026-06-04
Other
Legion Partners, LLC
Director · Common Stock · 2026-06-04
Other
Legion Partners, LLC
Director · Common Stock · 2026-06-04
Grant25.91K
Legion Partners Holdings, LLC
Director · Common Stock · 2026-06-04
Other
Legion Partners, L.P. I
Director · Common Stock · 2026-06-04
Other

SEC filings

EDGAR filings in LFCR · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.